Evidence map›Paper›PMID 38858185›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[A new concept from a global perspective for expanding the treatment of chronic hepatitis B].

X W Ai, M Y Zhang, Y M Sun, H You

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

X W AiLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
M Y ZhangLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Y M SunLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
H YouLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Funding

Beijing Municipal Science & Technology Commission Z221100007422115National Key Research and Development Program of China 2023YFC2306900
6 · The paper itself

Abstract

The global chronic hepatitis B (CHB) guidelines have gradually expanded treatment indications in order to accelerate the elimination and improve the treatment rate of hepatitis B virus (HBV) infection. This article analyzes the new treatment concepts for chronic hepatitis B at home and abroad from two aspects: expanding treatment by paying more attention to the long-term prognosis of the disease and maximizing the use of existing drugs in order to achieve the early goal of the World Health Organization's of eliminating viral hepatitis by 2030.

Indexed as

Antiviral AgentsHepatitis B, ChronicHepatitis B virusHumansWorld Health OrganizationAntiviral AgentsAntivirulenceChronic hepatitis BIndicationsTherapeutic

Identifiers

PMID38858185
PMCPMC12899077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.